Drug safety and pharmaceutical regulation in the age of global development-Reference-Cited by-同舟云学术

Drug safety and pharmaceutical regulation in the age of global development

Published:2020 Issue:3 Volume:2 Page:115-117
ISSN:2434-4974
Container-title:Translational and Regulatory Sciences
language:en
Short-container-title:

Author:

ONO Shunsuke¹

Affiliation:

1. Laboratory of Pharmaceutical Regulation and Science, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Hongo 7-3-1, Bunkyo-ku, Tokyo 113-0033, Japan

Publisher

AMED iD3 Catalyst Unit

Link

https://www.jstage.jst.go.jp/article/trs/2/3/2_2020-015/_pdf

Reference4 articles.

1. 1. Danzon, P. M., Wang, Y. R. and Wang, L. 2005. The impact of price regulation on the launch delay of new drugs--evidence from twenty-five major markets in the 1990s. Health Econ. 14: 269–292.

2. 2. Hirai, Y., Yamanaka, Y., Kusama, M., Ishibashi, T., Sugiyama, Y. and Ono, S. 2012. Analysis of the success rates of new drug development in Japan and the lag behind the US. Health Policy 104: 241–246.

3. 3. Yamada, T., Watanabe, Y., Kusama, M., Sugiyama, Y. and Ono, S. 2013. Factors associated with spontaneous reporting of adverse drug reactions in Japan. Pharmacoepidemiol. Drug Saf. 22: 468–476.

4. 4. Okubo, T. K. and Ono, S. 2019. Analysis of global drug development pathways and post-marketing safety in Japan: Local studies may reduce drug-related deaths. Clin. Transl. Sci. 12: 408–415.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global research publications on systemic use of off-label and unlicensed drugs: A bibliometric analysis (1990–2020);International Journal of Risk & Safety in Medicine;2021-07-14